Clinical Trial Update: Evaluation of Low-dose Irinotecan and Cyberknife® SBRT to Treat Colorectal Cancer With Limited Liver Metastasis [NA]

View source ↗

Summary

A clinical trial evaluating low-dose irinotecan in combination with CyberKnife SBRT for colorectal cancer with limited liver metastases has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Irinotecan (Irinotecan)

Snippet

Sponsor: Wake Forest University Health Sciences | Conditions: Colorectal Cancer | NA | Status: WITHDRAWN